Etranacogene dezaparvovec

Hemgenix

10000000000000 GENOME COPIES / ML SuspensionCanadaMarketedAuthorised 13 May 2026

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

HEMGENIX 1x10E13 COPIAS DEL GENOMA/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONSpain · 1x10E13 Copias genómicas · concentrado para solución para perfusión · Csl Behring GmbhSame brand
HemgenixEuropean Union · CSL Behring GmbHSame brand
HemgenixCroatiaSame brand
HemgenixItaly · Concentrato per soluzione per infusione · CSL Behring GMBHSame brand
Hemgenix 1x10E13 genoomkopieën/ml concentraat voor oplossing voor infusieNetherlands · Concentraat voor oplossing voor injectie of infusie · CSL Behring GmbHSame brand
HemgenixUnited States · 1X10E13GENOME COPIES/ML · Injection · CSL Behring LLCSame brand

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Etranacogene dezaparvovec

Hemgenix

10000000000000 GENOME COPIES / ML SuspensionCanadaMarketedAuthorised 13 May 2026

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Etranacogene dezaparvovec
Strength: 10000000000000 GENOME COPIES / ML
Dosage form: Suspension
Route: Intravenous
Register: Canada (Health Canada)
Status: Marketed
Authorised: 13 May 2026
Registration: DIN 02542560
Marketing authorisation holder: CSL Behring Canada INC
ATC code: B02BD16
Group: Blood and blood-forming organs
Supply: PRESCRIPTION, SCHEDULE D